Functionally distinct ALK and ROS1 fusions detected in infant-type hemispheric gliomas converge on STAT3 and SHP2 activation
Postlmayr, A.; Sanchez Bergman, A.; Torrejon Diaz, J.; Ciraulo, B.; Yan, S.; Hofmann, N.; Carbajal, S.; Dobler, R.; Machaalani, C.; Priego-Gonzalez, L.; De Micheli, A. J.; Berenjeno-Correa, E.; Baroncini, L.; Grotzer, M. A.; Tabori, U.; Hawkins, C.; Ayrault, O.; Zuckermann, M.; Baumgartner, M.; Guerreiro Stuecklin, A. S.
Show abstract
ALK and ROS1 fusions are emerging as key drivers of infant-type hemispheric gliomas (IHG). With diverse gene partners, the impact of ALK and ROS1 oncoprotein heterogeneity on glioma biology remains unknown. We developed an integrative phospho-proteomic and transcriptomic approach to discover biological functions regulated by five IHG-associated fusions: CCDC88A::ALK, PPP1CB::ALK, GOPC::ROS1, CLIP1::ROS1 and KIF21A::ROS1. Here, we report fusion-specific oncogenic functions conferred by the 5 gene partner, including increased cell motility driven by microtubule-interacting fusions CCDC88A::ALK and CLIP1::ROS1. All studied fusions converged on a non-canonical STAT3 activation. Using affinity purification mass spectrometry, we identify SHP2 in direct interaction with all three ROS1 oncoproteins, but with none of the ALK oncoproteins, which in turn interact with SHC1/SHC3. ROS1 fusions phosphorylated SHP2 to a larger extent than ALK fusions, and analyses of downstream pathways suggested MAPK-independent, non-canonical SHP2-driven functions. Our findings reveal both common and fusion-specific dependencies, offering opportunities to optimize therapeutic strategies for pediatric gliomas.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers 94%
- Isoform-specific functions of Numb in breast cancer progression, metastasis and proteome remodeling. 94%
- FRA1 drives melanoma metastasis through an actionable transcriptional network 93%
Similar papers in this journal
- Transcriptional Control of Brain Tumour Stem Cell by a Carbohydrate Binding Protein 96%
- The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability 95%
- NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas 95%
Similar papers in this journal
- Pyruvate carboxylation identifies Glioblastoma Stem-like Cells opening new metabolic strategy to prevent tumor recurrence 95%
- Neoplastic and Immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. 95%
- Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma 94%
Similar papers in this journal
- Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma 94%
- Clinically-relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance 94%
- Immunotherapy of glioblastoma explants induces interferon-γ responses and immune cell rearrangements in tumor center, but not periphery 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.